Atlas Trials

Minimum Dose CT Post Lung Biopsy

Clinical trial NCT00188162 · COMPLETED

Trial details

NCT number
NCT00188162
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lung Cancer
Start date
2004-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.